Back
Aurinia Pharmaceuticals Stock Price Chart
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
33
AUPH
Aurinia Pharmaceuticals
Last Price:
5.01
Seasonality Move:
0.53%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight selling pressure.
Aurinia Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.01 | Sell |
| 20-day SMA: | 5.04 | Sell |
| 50-day SMA: | 5.65 | Sell |
| 200-day SMA: | 8.05 | Sell |
| 8-day EMA: | 4.97 | Sell |
| 20-day EMA: | 5.1 | Sell |
| 50-day EMA: | 5.71 | Sell |
| 200-day EMA: | 7.52 | Sell |
Aurinia Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 34.96 | Sell |
| Chaikin Money Flow: | -354342 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.95 - 5.17) | Sell |
| Bollinger Bands (100): | (5.46 - 8.72) | Sell |
Aurinia Pharmaceuticals Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 4.81 while AUPH 8-day simple moving average is 5.01, which is a Sell signal.
- The stock price of AUPH is 4.81 while Aurinia Pharmaceuticals 20-day SMA is 5.04, which makes it a Sell.
- Aurinia Pharmaceuticals 50-day simple moving average is 5.65 while AUPH share price is 4.81, making it a Sell technically.
- AUPH stock price is 4.81 and Aurinia Pharmaceuticals 200-day simple moving average is 8.05, creating a Sell signal.
AUPH Technical Analysis vs Fundamental Analysis
Sell
33
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a Sell
The current Aurinia Pharmaceuticals [AUPH] share price is $4.81. The Score for AUPH is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
695.61M
Price in USD:
4.81
Share Volume:
1.93M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
12.43
52-Week Low:
4.71
Sell
33
Aurinia Pharmaceuticals (AUPH)
is a Sell
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?
The Aurinia Pharmaceuticals stock price is 4.81 USD today. -
Will AUPH stock go up or go down?
Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Aurinia Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 4.81 while AUPH 8-day exponential moving average is 4.97, which is a Sell signal.
- The stock price of AUPH is 4.81 while Aurinia Pharmaceuticals 20-day EMA is 5.10, which makes it a Sell.
- Aurinia Pharmaceuticals 50-day exponential moving average is 5.71 while AUPH share price is 4.81, making it a Sell technically.
- AUPH stock price is 4.81 and Aurinia Pharmaceuticals 200-day simple moving average is 7.52, creating a Sell signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.45 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
- AUPH Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Aurinia Pharmaceuticals is a Sell
- Aurinia Pharmaceuticals Relative Strength Index (RSI) is 34.96, which suggest Aurinia Pharmaceuticals is oversold
- The Bollinger Bands (25) for Aurinia Pharmaceuticals is (4.95 - 5.17), which suggest Aurinia Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Aurinia Pharmaceuticals is (5.46 - 8.72), which suggest Aurinia Pharmaceuticals is a Sell
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.